See also this year's filing and all EDGAR filings for this company.
PDF Report 0000744218_2016_Celldex_Therapeutics_Inc.pdf
Logs
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 12, '00201 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Calc 2)': 3}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000744218, Celldex Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 17,239,000 |
| 1 | LiabilitiesCurrent | 30,240,000 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 294,936,000 |
| 4 | AssetsNoncurrent | 1,428,000 |
| 5 | PropertyPlantAndEquipmentNet | 11,461,000 |
| 6 | Goodwill | 29,759,000 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 33,837,000 |
| 9 | ResearchAndDevelopmentExpense | 100,171,000 |
| 10 | remainder_Expenses | 1,013,000 |
| 11 | remainder_Revenues | 5,480,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 2,061,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 47,479,000 |
| 1 | Assets | 337,584,000 |
| 2 | Expenses | 135,021,000 |
| 3 | Revenues | 5,480,000 |
| 4 | StockholdersEquity | 290,105,000 |
| 5 | NetIncome | -129,541,000 |
| 6 | ComprehensiveNetIncome | -128,510,500 |
| 7 | BaseVar | 263,812,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.40 |
| 9 | EconomicCapitalRatio | 1.95 |
Edgar->Model Mapping
Feature Distribution
Change over Time
